Aksan, F. Et Al. 2023. S974 Efficacy and Safety of Adalimumab in Inducing Clinical Remission in Crohns Disease: A Meta-Analysis With Subgroup Analysis. 2023 ACG Annual Meeting , (Vancouver, Canada), 735-736.

Aksan, F., Tanrıverdi, L. H., & Monzur, F., (2023). S974 Efficacy and Safety of Adalimumab in Inducing Clinical Remission in Crohns Disease: A Meta-Analysis With Subgroup Analysis . 2023 ACG Annual Meeting (pp.735-736). Vancouver, Canada

Aksan, Feyzullah, LOKMAN HEKİM TANRIVERDİ, And Farah Monzur. "S974 Efficacy and Safety of Adalimumab in Inducing Clinical Remission in Crohns Disease: A Meta-Analysis With Subgroup Analysis," 2023 ACG Annual Meeting, Vancouver, Canada, 2023

Aksan, Feyzullah Et Al. "S974 Efficacy and Safety of Adalimumab in Inducing Clinical Remission in Crohns Disease: A Meta-Analysis With Subgroup Analysis." 2023 ACG Annual Meeting , Vancouver, Canada, pp.735-736, 2023

Aksan, F. Tanrıverdi, L. H. And Monzur, F. (2023) . "S974 Efficacy and Safety of Adalimumab in Inducing Clinical Remission in Crohns Disease: A Meta-Analysis With Subgroup Analysis." 2023 ACG Annual Meeting , Vancouver, Canada, pp.735-736.

@conferencepaper{conferencepaper, author={Feyzullah Aksan Et Al. }, title={S974 Efficacy and Safety of Adalimumab in Inducing Clinical Remission in Crohns Disease: A Meta-Analysis With Subgroup Analysis}, congress name={2023 ACG Annual Meeting}, city={Vancouver}, country={Canada}, year={2023}, pages={735-736} }